MFN1 expression based on
|
Comparison | Statistical significance |
Normal-vs-Primary | 1.373520E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.753400E-04 |
Normal-vs-Stage2 |
2.042300E-04 |
Normal-vs-Stage3 |
1.358000E-03 |
Normal-vs-Stage4 |
4.058400E-03 |
Stage1-vs-Stage2 |
2.530000E-01 |
Stage1-vs-Stage3 |
9.260600E-01 |
Stage1-vs-Stage4 |
9.914200E-01 |
Stage2-vs-Stage3 |
3.423400E-01 |
Stage2-vs-Stage4 |
3.494400E-01 |
Stage3-vs-Stage4 |
9.420200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.615800E-04 |
Normal-vs-AfricanAmerican |
3.866300E-02 |
Normal-vs-Asian |
1.319230E-03 |
Caucasian-vs-AfricanAmerican |
7.851400E-01 |
Caucasian-vs-Asian |
4.988400E-01 |
AfricanAmerican-vs-Asian |
4.740200E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.94579999996036E-06 |
Normal-vs-Female |
7.981700E-04 |
Male-vs-Female |
1.141990E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.479200E-03 |
Normal-vs-Age(41-60Yrs) |
4.16850000000135E-05 |
Normal-vs-Age(61-80Yrs) |
1.915570E-03 |
Normal-vs-Age(81-100Yrs) |
1.266180E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.571380E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.895400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.285200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.313000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.150400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.101200E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
6.106000E-01 |
Classical-VS-Follicular |
4.169600E-04 |
Classical-VS-Other |
2.545400E-01 |
Classical-VS-Normal |
2.981100E-03 |
Tall-VS-Follicular |
1.702310E-02 |
Tall-VS-Other |
1.526440E-01 |
Tall-VS-Normal |
1.030770E-01 |
Follicular-VS-Other |
9.435400E-01 |
Follicular-VS-Normal |
2.05009999998396E-06 |
Other-VS-Normal |
1.918130E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.98629999998068E-06 |
Normal-vs-N1 |
3.758500E-03 |
N0-vs-N1 |
3.679600E-01 |
|
|